Varian Medical Systems (VAR) 84.36 $VAR
Varian and Russian Proton Therapy Center Achieve Milestone with Cyclotron Installation
PR Newswire - Thu Jun 09, 7:00AM CDT
Russia's first dedicated proton therapy treatment center achieved a major milestone this week with the installation of the cyclotron by equipment supplier Varian Medical Systems (NYSE: VAR). The installation, a key milestone for each new proton therapy center, involved the cyclotron being lifted into position by cranes in a procedure that was watched by local government officials including the governor of St. Petersburg.
VAR: 84.36 (-0.94)
Varian Keeps Up the Winning Streak in Turkey, Expands Base
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:39AM CDT
Varian Medical Systems Inc (VAR) is on a roll, winning a string of orders in Turkey.
IRMD: 20.19 (-1.16), MASI: 51.73 (-0.37), VAR: 84.36 (-0.94), CRY: 11.97 (+0.09)
Varian to Showcase Imaging Solutions At 19th World Conference On Non-destructive Testing
PR Newswire - Wed Jun 08, 7:15AM CDT
Varian Medical Systems (NYSE: VAR), today announced plans to demonstrate its security and industrial imaging solutions June 13-17 in Munich Germany at the 19th World Conference on Non-destructive Testing (WCNDT), booth FE73.
VAR: 84.36 (-0.94), MDSY: 1.51 (+0.01)
Varian Extending Advanced Cancer Care in Turkey
PR Newswire - Tue Jun 07, 7:00AM CDT
Cancer patients in Turkey will gain access to advanced radiotherapy treatments with news that Varian Medical Systems (NYSE: VAR), world leader in radiotherapy and radiosurgery, has been selected to supply multiple treatment machines to public and private hospitals in the country. To date this year, Varian has booked orders for more than 20 medical linear accelerators from Turkish hospitals. The new systems will be delivered over the next 18 months.
VAR: 84.36 (-0.94), MDSY: 1.51 (+0.01)
Technical Pulse on Medical Appliances & Equipment Stocks -- St. Jude Medical, ResMed, Steris, and Varian Medical Systems
PR Newswire - Mon Jun 06, 8:00AM CDT
On Friday, June 03, 2016, the NASDAQ Composite ended the trading session at 4,942.52, down 0.58%; the Dow Jones Industrial Average lost 0.18% to finish at 17,807.06; and the S&P 500 closed at 2,099.13, down 0.29%. ActiveWallSt.com has initiated coverage on the following equities: St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE: RMD), Steris PLC (NYSE: STE), and Varian Medical Systems Inc. (NYSE: VAR). Learn more about these stocks by accessing their free trade alerts at:
VAR: 84.36 (-0.94), STE: 68.78 (-1.96), RMD: 59.69 (-0.11), STJ: 77.17 (-0.18), MDSY: 1.51 (+0.01)
Varian Medical Systems Announces Plan to Spin Off Imaging Components Business
PR Newswire - Mon May 23, 3:05PM CDT
Varian Medical Systems (NYSE:VAR) today announced that it plans to spin off its Imaging Components business as a new, stand-alone public company via a tax-free distribution to Varian stockholders in a transaction anticipated to be completed by the end of calendar year 2016.
VAR: 84.36 (-0.94)
MD Anderson and Varian Expand Relationship with Acquisition of TrueBeam Systems
PR Newswire - Mon May 23, 7:15AM CDT
Varian Medical Systems (NYSE: VAR) has announced The University of Texas MD Anderson Cancer Center signed an agreement to acquire six TrueBeam(TM) linear accelerators. Scheduled for delivery over the next 24 months, the six TrueBeam systems will be added to the 24 Varian linear accelerators already treating patients at the cancer center.
VAR: 84.36 (-0.94)
Largest Hospital Chain in India Selects Varian Advanced Radiotherapy Equipment
PR Newswire - Thu May 19, 7:00AM CDT
Varian Medical Systems (NYSE: VAR) has been selected by the Apollo Hospitals Group to supply 12 advanced medical linear accelerators and five brachytherapy systems as India's largest private hospital chain rolls out a program to replace ageing cancer treatment machines. Based on an order placed in March, Varian will supply 11 TrueBeam® systems, one Edge(TM) Radiosurgery system, and five GammaMed® brachytherapy systems for the Apollo network over the next two years.
VAR: 84.36 (-0.94)
Varian Medical Systems Rises 1.80% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon May 16, 3:45PM CDT
Varian Medical Systems (NYSE:VAR) traded in a range yesterday that spanned from a low of $82.04 to a high of $83.77. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $82.77 on volume of 297,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VAR: 84.36 (-0.94)
Varian Selected to Provide Planning Software for New UK Proton Therapy Center
PR Newswire - Thu May 12, 7:00AM CDT
Varian Medical Systems (NYSE: VAR), leader in radiotherapy systems and software for the treatment of cancer, has been selected by The Christie NHS Foundation Trust to provide Eclipse treatment planning software for the proton center currently under construction at the Manchester hospital. Varian is already supplying treatment equipment for the two UK national proton centers being constructed at The Christie and at University College Hospital in London.
VAR: 84.36 (-0.94)
Varian Medical Systems Starts Equipment Installation at New Proton Therapy Center in Netherlands
PR Newswire - Tue May 10, 7:00AM CDT
Varian Medical Systems (NYSE: VAR) today delivered the cyclotron for the new multi-room HollandPTC in Delft, which will be equipped with the Varian ProBeam® proton therapy system. The cyclotron, a particle accelerator which accelerates protons to two thirds of the speed of light for clinical use, is a core piece of equipment of the ProBeam® system. The delivery marks the start of equipment installation, a key milestone for each new proton therapy center.
VAR: 84.36 (-0.94)
Varian Medical Systems Releases Software for Simplifying X-ray System Design
PR Newswire - Mon May 09, 7:15AM CDT
Varian Medical Systems, Inc. (NYSE: VAR), today announced the release of new computer aided engineering (CAE) software for simplifying the process of designing shielding and radiological protection systems. Varian's new Attila4MC software provides engineers, using Monte Carlo N-Particle Code (MCNP®) in their product designs, with an intuitive graphical user interface (GUI) that simplifies and accelerates the calculation process. Varian further expects Attila4MC to be particularly useful for research involving medical physics and nuclear engineering.
VAR: 84.36 (-0.94)
IntelliCorp Catalyzes Migrations to the SAP HANA® Platform
PR Newswire - Thu May 05, 8:00AM CDT
WHO/WHAT:
VAR: 84.36 (-0.94)
Medical Robots Transforming Healthcare 2016: Pricing & Cost-Benefit Assessment Featuring Elekta, Hocoma, Intuitive Surgicals, Mazor Robotics, Rewalk & Varian Medical Systems
GlobeNewswire - Wed May 04, 4:10AM CDT
Research and Markets has announced the addition of the "Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment, by Product, by Application, by Geography, Reimbursement, Selection Criteria and Buying Cycle" report to their offering.
VAR: 84.36 (-0.94), MZOR: 16.00 (+0.22)
Varian (VAR) Beats Q2 Earnings by a Penny, Lags Revenues
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 8:19AM CDT
Varian Medical Systems Inc. (VAR) reported earnings of $1.09 per share in the second quarter of fiscal 2016, which beat the Zacks Consensus Estimate by a penny.
RTIX: 3.92 (+0.21), VAR: 84.36 (-0.94), INGN: 49.29 (-0.17), EXAC: 25.72 (+0.30)
Varian Gives European Clinicians First Glimpse of Next Big Advance in Radiotherapy at ESTRO 35
PR Newswire - Thu Apr 28, 7:00AM CDT
Varian Medical Systems will demonstrate its full range of radiotherapy delivery systems at the 35th ESTRO (European Society for Radiotherapy and Oncology) meeting, taking place here in Turin from April 29th-May 3rd. The Varian booth features the company's technology and products for radiotherapy, radiosurgery, brachytherapy, and proton therapy, and will offer the European clinical community its first glimpse of High Definition Radiotherapy (HDRT).
VAR: 84.36 (-0.94)
Varian beats 2Q profit forecasts
Automated Insights - Wed Apr 27, 4:15PM CDT
PALO ALTO, Calif. (AP) _ Varian Medical Systems Inc. (VAR) on Wednesday reported fiscal second-quarter net income of $97 million.
VAR: 84.36 (-0.94)
Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2016
PR Newswire - Wed Apr 27, 3:44PM CDT
Varian Medical Systems (NYSE:VAR) today is reporting non-GAAP net earnings of $1.09 per diluted share and GAAP net earnings of $1.01 per diluted share for the second quarter of fiscal year 2016. Varian's revenues totaled $759 million for the second quarter, equal to the year-ago quarter and up 2 percent in constant currency. The company ended the quarter with a $3.3 billion backlog, up 6 percent from the end of the second quarter of fiscal year 2015.
VAR: 84.36 (-0.94)
Proton Therapy Center Initiates 3D Image Guided Proton Therapy to Enhance Precision of Cancer Care
PR Newswire - Wed Apr 27, 7:15AM CDT
Varian Medical Systems (NYSE: VAR), today announced that its 3D volumetric imaging technology is now being used at a California proton therapy center to enhance the precision and quality of its treatments for cancer patients. The treatments with image-guided intensity modulated proton therapy (IMPT) are being delivered on Varian's ProBeam® system at Scripps Proton Therapy Center in San Diego.
VAR: 84.36 (-0.94)
Investor Calendar Invites You to the Varian Medical Systems Second Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday, April 27, 2016
ACCESSWIRE - Tue Apr 26, 3:15PM CDT
PALO ALTO, CA / ACCESSWIRE / April 26, 2016 / Varian Medical Systems (NYSE: VAR) will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held Wednesday, April 27, 2016 at 5:00 PM Eastern Time.
VAR: 84.36 (-0.94), MDSY: 1.51 (+0.01)
Varian and Russian Proton Therapy Center Achieve Milestone with Cyclotron Installation
PR Newswire - Thu Jun 09, 7:00AM CDT
Russia's first dedicated proton therapy treatment center achieved a major milestone this week with the installation of the cyclotron by equipment supplier Varian Medical Systems (NYSE: VAR). The installation, a key milestone for each new proton therapy center, involved the cyclotron being lifted into position by cranes in a procedure that was watched by local government officials including the governor of St. Petersburg.
VAR: 84.36 (-0.94)
Varian Keeps Up the Winning Streak in Turkey, Expands Base
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:39AM CDT
Varian Medical Systems Inc (VAR) is on a roll, winning a string of orders in Turkey.
IRMD: 20.19 (-1.16), MASI: 51.73 (-0.37), VAR: 84.36 (-0.94), CRY: 11.97 (+0.09)
Varian to Showcase Imaging Solutions At 19th World Conference On Non-destructive Testing
PR Newswire - Wed Jun 08, 7:15AM CDT
Varian Medical Systems (NYSE: VAR), today announced plans to demonstrate its security and industrial imaging solutions June 13-17 in Munich Germany at the 19th World Conference on Non-destructive Testing (WCNDT), booth FE73.
VAR: 84.36 (-0.94), MDSY: 1.51 (+0.01)
Varian Extending Advanced Cancer Care in Turkey
PR Newswire - Tue Jun 07, 7:00AM CDT
Cancer patients in Turkey will gain access to advanced radiotherapy treatments with news that Varian Medical Systems (NYSE: VAR), world leader in radiotherapy and radiosurgery, has been selected to supply multiple treatment machines to public and private hospitals in the country. To date this year, Varian has booked orders for more than 20 medical linear accelerators from Turkish hospitals. The new systems will be delivered over the next 18 months.
VAR: 84.36 (-0.94), MDSY: 1.51 (+0.01)
Technical Pulse on Medical Appliances & Equipment Stocks -- St. Jude Medical, ResMed, Steris, and Varian Medical Systems
PR Newswire - Mon Jun 06, 8:00AM CDT
On Friday, June 03, 2016, the NASDAQ Composite ended the trading session at 4,942.52, down 0.58%; the Dow Jones Industrial Average lost 0.18% to finish at 17,807.06; and the S&P 500 closed at 2,099.13, down 0.29%. ActiveWallSt.com has initiated coverage on the following equities: St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE: RMD), Steris PLC (NYSE: STE), and Varian Medical Systems Inc. (NYSE: VAR). Learn more about these stocks by accessing their free trade alerts at:
VAR: 84.36 (-0.94), STE: 68.78 (-1.96), RMD: 59.69 (-0.11), STJ: 77.17 (-0.18), MDSY: 1.51 (+0.01)
Varian Medical Systems Announces Plan to Spin Off Imaging Components Business
PR Newswire - Mon May 23, 3:05PM CDT
Varian Medical Systems (NYSE:VAR) today announced that it plans to spin off its Imaging Components business as a new, stand-alone public company via a tax-free distribution to Varian stockholders in a transaction anticipated to be completed by the end of calendar year 2016.
VAR: 84.36 (-0.94)
MD Anderson and Varian Expand Relationship with Acquisition of TrueBeam Systems
PR Newswire - Mon May 23, 7:15AM CDT
Varian Medical Systems (NYSE: VAR) has announced The University of Texas MD Anderson Cancer Center signed an agreement to acquire six TrueBeam(TM) linear accelerators. Scheduled for delivery over the next 24 months, the six TrueBeam systems will be added to the 24 Varian linear accelerators already treating patients at the cancer center.
VAR: 84.36 (-0.94)
Largest Hospital Chain in India Selects Varian Advanced Radiotherapy Equipment
PR Newswire - Thu May 19, 7:00AM CDT
Varian Medical Systems (NYSE: VAR) has been selected by the Apollo Hospitals Group to supply 12 advanced medical linear accelerators and five brachytherapy systems as India's largest private hospital chain rolls out a program to replace ageing cancer treatment machines. Based on an order placed in March, Varian will supply 11 TrueBeam® systems, one Edge(TM) Radiosurgery system, and five GammaMed® brachytherapy systems for the Apollo network over the next two years.
VAR: 84.36 (-0.94)
Varian Medical Systems Rises 1.80% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon May 16, 3:45PM CDT
Varian Medical Systems (NYSE:VAR) traded in a range yesterday that spanned from a low of $82.04 to a high of $83.77. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $82.77 on volume of 297,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VAR: 84.36 (-0.94)
Varian Selected to Provide Planning Software for New UK Proton Therapy Center
PR Newswire - Thu May 12, 7:00AM CDT
Varian Medical Systems (NYSE: VAR), leader in radiotherapy systems and software for the treatment of cancer, has been selected by The Christie NHS Foundation Trust to provide Eclipse treatment planning software for the proton center currently under construction at the Manchester hospital. Varian is already supplying treatment equipment for the two UK national proton centers being constructed at The Christie and at University College Hospital in London.
VAR: 84.36 (-0.94)
Varian Medical Systems Starts Equipment Installation at New Proton Therapy Center in Netherlands
PR Newswire - Tue May 10, 7:00AM CDT
Varian Medical Systems (NYSE: VAR) today delivered the cyclotron for the new multi-room HollandPTC in Delft, which will be equipped with the Varian ProBeam® proton therapy system. The cyclotron, a particle accelerator which accelerates protons to two thirds of the speed of light for clinical use, is a core piece of equipment of the ProBeam® system. The delivery marks the start of equipment installation, a key milestone for each new proton therapy center.
VAR: 84.36 (-0.94)
Varian Medical Systems Releases Software for Simplifying X-ray System Design
PR Newswire - Mon May 09, 7:15AM CDT
Varian Medical Systems, Inc. (NYSE: VAR), today announced the release of new computer aided engineering (CAE) software for simplifying the process of designing shielding and radiological protection systems. Varian's new Attila4MC software provides engineers, using Monte Carlo N-Particle Code (MCNP®) in their product designs, with an intuitive graphical user interface (GUI) that simplifies and accelerates the calculation process. Varian further expects Attila4MC to be particularly useful for research involving medical physics and nuclear engineering.
VAR: 84.36 (-0.94)
IntelliCorp Catalyzes Migrations to the SAP HANA® Platform
PR Newswire - Thu May 05, 8:00AM CDT
WHO/WHAT:
VAR: 84.36 (-0.94)
Medical Robots Transforming Healthcare 2016: Pricing & Cost-Benefit Assessment Featuring Elekta, Hocoma, Intuitive Surgicals, Mazor Robotics, Rewalk & Varian Medical Systems
GlobeNewswire - Wed May 04, 4:10AM CDT
Research and Markets has announced the addition of the "Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment, by Product, by Application, by Geography, Reimbursement, Selection Criteria and Buying Cycle" report to their offering.
VAR: 84.36 (-0.94), MZOR: 16.00 (+0.22)
Varian (VAR) Beats Q2 Earnings by a Penny, Lags Revenues
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 8:19AM CDT
Varian Medical Systems Inc. (VAR) reported earnings of $1.09 per share in the second quarter of fiscal 2016, which beat the Zacks Consensus Estimate by a penny.
RTIX: 3.92 (+0.21), VAR: 84.36 (-0.94), INGN: 49.29 (-0.17), EXAC: 25.72 (+0.30)
Varian Gives European Clinicians First Glimpse of Next Big Advance in Radiotherapy at ESTRO 35
PR Newswire - Thu Apr 28, 7:00AM CDT
Varian Medical Systems will demonstrate its full range of radiotherapy delivery systems at the 35th ESTRO (European Society for Radiotherapy and Oncology) meeting, taking place here in Turin from April 29th-May 3rd. The Varian booth features the company's technology and products for radiotherapy, radiosurgery, brachytherapy, and proton therapy, and will offer the European clinical community its first glimpse of High Definition Radiotherapy (HDRT).
VAR: 84.36 (-0.94)
Varian beats 2Q profit forecasts
Automated Insights - Wed Apr 27, 4:15PM CDT
PALO ALTO, Calif. (AP) _ Varian Medical Systems Inc. (VAR) on Wednesday reported fiscal second-quarter net income of $97 million.
VAR: 84.36 (-0.94)
Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2016
PR Newswire - Wed Apr 27, 3:44PM CDT
Varian Medical Systems (NYSE:VAR) today is reporting non-GAAP net earnings of $1.09 per diluted share and GAAP net earnings of $1.01 per diluted share for the second quarter of fiscal year 2016. Varian's revenues totaled $759 million for the second quarter, equal to the year-ago quarter and up 2 percent in constant currency. The company ended the quarter with a $3.3 billion backlog, up 6 percent from the end of the second quarter of fiscal year 2015.
VAR: 84.36 (-0.94)
Proton Therapy Center Initiates 3D Image Guided Proton Therapy to Enhance Precision of Cancer Care
PR Newswire - Wed Apr 27, 7:15AM CDT
Varian Medical Systems (NYSE: VAR), today announced that its 3D volumetric imaging technology is now being used at a California proton therapy center to enhance the precision and quality of its treatments for cancer patients. The treatments with image-guided intensity modulated proton therapy (IMPT) are being delivered on Varian's ProBeam® system at Scripps Proton Therapy Center in San Diego.
VAR: 84.36 (-0.94)
Investor Calendar Invites You to the Varian Medical Systems Second Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday, April 27, 2016
ACCESSWIRE - Tue Apr 26, 3:15PM CDT
PALO ALTO, CA / ACCESSWIRE / April 26, 2016 / Varian Medical Systems (NYSE: VAR) will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held Wednesday, April 27, 2016 at 5:00 PM Eastern Time.
VAR: 84.36 (-0.94), MDSY: 1.51 (+0.01)
